Lava Therapeutics NVLVTX
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 19 institutions reported holding Lava Therapeutics NV (LVTX) in their 13F filings, down 1 from Q1 2024. 3 opened new positions and 3 sold out. The largest holders were Redmile Group, LLC ($3.7M), Bruce & Co., Inc. ($1.4M) and Sphera Funds Management LTD. ($662K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Lava Therapeutics NV
- CUSIP
- N51517105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $184K |
| Exits | 3 | $134K |
All 13F filers, Q1 2024 → Q2 2024: 205,426 shares bought and 207,062 shares sold, net −1,636 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Redmile Group, LLC | 0.23% | No change | 2,074,372 | $3.7M |
| Bruce & Co., Inc. | 0.46% | No change | 771,874 | $1.4M |
| Sphera Funds Management LTD. | 0.11% | No change | 367,582 | $662K |
| Two Sigma Investments, LP | 0.00% | Add +37.1% | 112,439 | $202K |
| Alpha Wave Global, LP | 0.05% | Reduce -19.0% | 87,397 | $157K |
| Citadel Advisors | 0.00% | New | 66,237 | $119K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 65,000 | $117K |
| Pathway Financial Advisors LLC | 0.03% | Add +328.6% | 60,000 | $108K |
| Two Sigma Advisers, LP | 0.00% | Add +89.8% | 31,700 | $57K |
| XTX Topco Ltd | 0.00% | New | 30,807 | $55K |
| Millennium Management | 0.00% | Add +32.3% | 26,493 | $48K |
| Walleye Capital LLC | 0.00% | Reduce -83.4% | 25,675 | $46K |
| Morgan Stanley | 0.00% | Add +52.9% | 15,600 | $28K |
| Geode Capital Management, LLC | 0.00% | No change | 11,124 | $20K |
| CIBC Private Wealth Group LLC | 0.00% | No change | 6,000 | $11K |
| Tang Capital Management LLC | 0.00% | New | 5,109 | $9K |
| Tsfg, LLC | 0.00% | No change | 400 | $1K |
| Bank of America Corp. | 0.00% | Reduce -97.4% | 400 | $720 |
| Simplex Trading, LLC | 0.00% | Reduce -91.3% | 226 | $0 |
"% of holder's portfolio" is LVTX's weight in each manager's 13F, not the share of Lava Therapeutics NV the manager owns.